On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its debut on the SIX Swiss Exchange, officially launching Switzerland’s IPO season for the year. With an opening share price of CHF 36.50, BioVersys reached a [...]
More news
On the evening of April 9, 2025, The Voltahalle in Basel was the stage of [...]
AdjuTec Pharma AS - 3rd place winner of the Poster Competition at the 9th AMR [...]
INCATE kicked off the AMR week in Basel with the INCATE Networking Event on February [...]
Our colleague Helmut Kessmann has decided his time has come to retire and embark on new [...]
The INCATE Selection Committee selected the new 4 ventures for Stage I support. Meet the [...]
The AMR Conference 2025 has reached another milestone as the finalists for this year’s Poster [...]
A&J Science, an innovative biotech company based in South Korea and dedicated to addressing AMR, [...]
After receiving over 40 impressive applications and conducting a rigorous selection process, we are ready [...]
